Elixinol Wellness Limited ELLXF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 61.62% | 61.68% | -334.46% | -327.31% | -9.10% |
| Total Depreciation and Amortization | -18.88% | -19.03% | -28.57% | -30.79% | -7.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -101.38% | -101.38% | -340.96% | -333.73% | 1,473.77% |
| Change in Net Operating Assets | -- | -- | 124.60% | 123.85% | -- |
| Cash from Operations | 42.96% | 43.04% | -39.29% | -35.03% | 37.32% |
| Capital Expenditure | -78.57% | -78.05% | -248.98% | -240.00% | 71.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 74.98% | 75.73% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 14.81% | 15.09% | -- | -- | -100.72% |
| Cash from Investing | 147.92% | 147.87% | 61.47% | 62.65% | -106.94% |
| Total Debt Issued | -71.60% | -71.60% | -75.84% | -75.84% | -- |
| Total Debt Repaid | 4.21% | 4.21% | 75.83% | 75.83% | 44.77% |
| Issuance of Common Stock | -- | -- | 69.77% | 69.77% | -95.26% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -93.49% | -93.49% | 96.96% |
| Cash from Financing | -76.47% | -76.50% | 68.82% | 63.63% | -46.06% |
| Foreign Exchange rate Adjustments | 6.56% | 6.67% | 1,900.00% | 1,891.30% | -510.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5,106.90% | -5,167.86% | 164.21% | 162.20% | -98.99% |